Clinical Trial Update: A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SHR3680, HS-20093, and SHR2554 in prostate cancer is currently recruiting. No results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HS-20093
• SHR2554
• SHR3680

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING